The successful candidate will be required to carry out research as part of a pre-clinical and early clinical trial programme for the gene therapy for rare disorders (Tay-Sachs and related conditions) affecting the CNS due to lysosomal defects (see Cachón-González et al PNAS 2006; 103: 19373-78; Mol Therapy 2012; 20:1489-500; Hum Mol Genet 2014; 23:730-48; Bradbury et al Mol Therapy 2013;21:1306-15).
The research will involve the evaluation of functional benefit, transduced tissues, and studies related to the molecular pathogenesis of glycolipid storage.
We seek a Scientist, who wishes to develop their skills in molecular cell pathology and biochemical analysis and clinical gene transfer. Experience in neuro-anatomy and pathology would be advantageous.
Maternity cover: This post is fixed-term for 1 years or the return of the post holder, whichever is the earlier.
Once an offer of employment has been accepted, the successful candidate will be required to undergo a basic disclosure (criminal records check) check, a health assessment and a security check.
To apply online for this vacancy, please click on the 'Apply' button below. This will route you to the University's Web Recruitment System, where you will need to register an account (if you have not already) and log in before completing the online application form.
Please ensure that you upload a covering letter and CV in the Upload section of the online application. If you upload any additional documents which have not been requested, we will not be able to consider these as part of your application.
Please include details of your referees, including email address and phone number, one of which must be your most recent line manager.
Closing date for applications is the 17th October 2017, with interview dates yet to be confirmed by the department.
Please quote reference RC13358 on your application and in any correspondence about this vacancy.
The University values diversity and is committed to equality of opportunity.
The University has a responsibility to ensure that all employees are eligible to live and work in the UK.